Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myosin-Light-Chain Kinase | 2 | 2018 | 40 | 1.380 |
Why?
|
| Alternative Splicing | 2 | 2018 | 191 | 1.260 |
Why?
|
| Paired Box Transcription Factors | 4 | 2012 | 51 | 1.020 |
Why?
|
| Endothelial Cells | 2 | 2021 | 402 | 0.770 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2018 | 30 | 0.730 |
Why?
|
| Calcium-Binding Proteins | 1 | 2018 | 115 | 0.690 |
Why?
|
| Stress, Mechanical | 1 | 2017 | 255 | 0.610 |
Why?
|
| Transcriptional Activation | 2 | 2018 | 287 | 0.530 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2010 | 1209 | 0.530 |
Why?
|
| Repressor Proteins | 3 | 2018 | 409 | 0.520 |
Why?
|
| Lung | 2 | 2021 | 1061 | 0.510 |
Why?
|
| Melanoma | 3 | 2013 | 507 | 0.450 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2010 | 202 | 0.440 |
Why?
|
| Eye Proteins | 2 | 2009 | 130 | 0.440 |
Why?
|
| SOXE Transcription Factors | 1 | 2010 | 6 | 0.420 |
Why?
|
| Receptors, Growth Factor | 1 | 2009 | 56 | 0.400 |
Why?
|
| Homeodomain Proteins | 2 | 2009 | 546 | 0.360 |
Why?
|
| Disease Progression | 2 | 2010 | 1474 | 0.350 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 2338 | 0.350 |
Why?
|
| Pancreatic Neoplasms | 2 | 2009 | 674 | 0.320 |
Why?
|
| Exons | 2 | 2018 | 461 | 0.300 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2009 | 677 | 0.290 |
Why?
|
| HEK293 Cells | 2 | 2018 | 642 | 0.290 |
Why?
|
| Paxillin | 1 | 2021 | 61 | 0.220 |
Why?
|
| Acute Lung Injury | 1 | 2021 | 54 | 0.210 |
Why?
|
| Base Sequence | 3 | 2017 | 2430 | 0.210 |
Why?
|
| Cell Line, Tumor | 5 | 2018 | 2426 | 0.190 |
Why?
|
| Replication Protein A | 1 | 2018 | 16 | 0.190 |
Why?
|
| Pulmonary Stretch Receptors | 1 | 2018 | 3 | 0.190 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2018 | 36 | 0.190 |
Why?
|
| Reactive Oxygen Species | 1 | 2021 | 459 | 0.190 |
Why?
|
| Electric Impedance | 1 | 2018 | 102 | 0.180 |
Why?
|
| Capillary Permeability | 1 | 2018 | 135 | 0.170 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2018 | 72 | 0.170 |
Why?
|
| Introns | 1 | 2018 | 282 | 0.170 |
Why?
|
| Consensus Sequence | 1 | 2017 | 63 | 0.170 |
Why?
|
| RNA Splice Sites | 1 | 2017 | 50 | 0.170 |
Why?
|
| Mice | 5 | 2021 | 11133 | 0.150 |
Why?
|
| Binding Sites | 1 | 2018 | 1122 | 0.150 |
Why?
|
| Lymphocytes | 1 | 2017 | 477 | 0.140 |
Why?
|
| Apoptosis | 3 | 2012 | 1775 | 0.140 |
Why?
|
| Protein Binding | 1 | 2018 | 1509 | 0.130 |
Why?
|
| Transcription, Genetic | 1 | 2018 | 1167 | 0.130 |
Why?
|
| Computational Biology | 1 | 2017 | 530 | 0.130 |
Why?
|
| Melanocytes | 1 | 2013 | 58 | 0.130 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2012 | 61 | 0.120 |
Why?
|
| Computer Simulation | 1 | 2017 | 1059 | 0.120 |
Why?
|
| Adenocarcinoma | 2 | 2009 | 1195 | 0.110 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 2299 | 0.110 |
Why?
|
| Stem Cells | 1 | 2013 | 353 | 0.100 |
Why?
|
| Humans | 9 | 2021 | 83447 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 2674 | 0.100 |
Why?
|
| Animals | 5 | 2021 | 26985 | 0.100 |
Why?
|
| Genes, Reporter | 1 | 2009 | 268 | 0.090 |
Why?
|
| Skin Neoplasms | 1 | 2013 | 538 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 568 | 0.090 |
Why?
|
| RNA | 1 | 2010 | 515 | 0.080 |
Why?
|
| Cell Differentiation | 2 | 2013 | 1474 | 0.070 |
Why?
|
| Cell Line | 2 | 2021 | 2615 | 0.070 |
Why?
|
| Neoplasm Metastasis | 1 | 2009 | 1047 | 0.070 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 3194 | 0.070 |
Why?
|
| Phenotype | 1 | 2009 | 2295 | 0.060 |
Why?
|
| Tyrosine | 1 | 2021 | 147 | 0.060 |
Why?
|
| Lipopolysaccharides | 1 | 2021 | 277 | 0.050 |
Why?
|
| Response Elements | 1 | 2018 | 66 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2021 | 1158 | 0.050 |
Why?
|
| Mutation | 1 | 2009 | 3862 | 0.040 |
Why?
|
| Genome | 1 | 2018 | 360 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 942 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 3180 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 1524 | 0.030 |
Why?
|
| Maleimides | 1 | 2012 | 31 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2018 | 1212 | 0.030 |
Why?
|
| RNA Interference | 1 | 2012 | 378 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2013 | 191 | 0.030 |
Why?
|
| Indoles | 1 | 2012 | 335 | 0.030 |
Why?
|
| Cell Survival | 1 | 2012 | 1012 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2008 | 97 | 0.020 |
Why?
|
| DNA Primers | 1 | 2008 | 571 | 0.020 |
Why?
|
| Cell Division | 1 | 2008 | 750 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2012 | 1613 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 369 | 0.020 |
Why?
|
| Models, Biological | 1 | 2013 | 1798 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2012 | 3301 | 0.010 |
Why?
|
| Rats | 1 | 2008 | 4351 | 0.010 |
Why?
|